Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
February 28, 2023 07:30 ET
|
Cronos Group Inc.
Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 ...
Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023
February 14, 2023 09:25 ET
|
Cronos Group Inc.
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 fourth quarter and full-year earnings conference call on...
Spinach® Becomes the Number One Edible Brand in January¹
February 08, 2023 07:30 ET
|
Cronos Group Inc.
Spinach® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX:...
Cronos Group Inc. Announces Receipt of Notice of Relinquishment of Warrant by Altria
December 19, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that on December 16, 2022, Altria Group, Inc. (“Altria”) notified...
Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
December 07, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced the launch of a CBC-focused product, the...
Cronos Group Inc. to Speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference
November 29, 2022 16:35 ET
|
Cronos Group Inc.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...
Cronos Group Appoints James Holm as Chief Financial Officer
November 14, 2022 07:30 ET
|
Cronos Group Inc.
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of...
Cronos Group Reports 2022 Third Quarter Results
November 07, 2022 07:30 ET
|
Cronos Group Inc.
Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net...
Cronos Group Inc. Announces Final Settlement Agreements
October 24, 2022 17:44 ET
|
Cronos Group Inc.
TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that it has reached final settlement agreements with each of the...
Cronos Group Inc. to Hold 2022 Third Quarter Earnings Conference Call on November 7, 2022
October 17, 2022 16:15 ET
|
Cronos Group Inc.
TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 third quarter earnings conference call on Monday, November 7,...